MSD's Keytruda is poised to end a 20-year drought in new advances in NHS treatment for early-stage head and neck cancer, ...

Head and neck squamous cell carcinomas (HNSCC) are the seventh-most prevalent form of cancer and are associated with human ...

The UK’s National Institute for Health and Care Excellence (NICE) has recommended the use of Keytruda (pembrolizumab), within its marketing authorization, for patients identified for surgery with ...

TG4050, Transgene’s first INTV, demonstrated durable clinical outcomes in resected head and neck squamous cell carcinoma (HNSCC) and potential to prevent cancer relapse "Together with the updated ...

Neoadjuvant chemoimmunotherapy may beat immunotherapy alone when it comes to pathologic response, but its impact on survival remains to be seen.

A new analysis explores whether accelerating RT delivery with 6 fractions vs 5 fractions per week improves outcomes in ...

Caris Life Sciences® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine ...

Researchers discovered that exposing cancer cells to vibration mimicking vocal cord movement reduced their malignancy.

Caris Life Sciences reports another breakthrough study for GPSai in identifying and correcting misdiagnosis of cancer patients: Irving, Texas Monday, March 23, 2026, 16:00 Hrs [IS ...

The health condition can cause throat or oropharyngeal cancer in high-risk cases, though many of the symptoms which indicate ...